Publications by authors named "Celestino Sardu"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

12,445,559

Total Likes

446,753

Extended Reach

14,747,113

Social Features

385
M
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events.
Raffaele Marfella, Francesco Prattichizzo, Celestino Sardu, Gianluca Fulgenzi, Laura Graciotti, Tatiana Spadoni, Nunzia D'Onofrio, Lucia Scisciola, Rosalba La Grotta, Chiara Frigé

March 2024

Videos about Article: user user user 27

30 6 17 349 51 804 2

View All Article and Social Media Activity
I
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study.
Alfredo Caturano, Raffaele Galiero, Vittorio Simeon, Carlo Acierno, Davide Nilo, Celestino Sardu

Nutr Metab Cardiovasc Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial dysfunction and cardiovascular outcomes in pre-menopausal women with high vs low breast fat accumulation: The role of TSP-1.
Celestino Sardu, Giovanni Francesco Nicoletti, Maria Consiglia Trotta, Gorizio Pieretti, Gianluca Gatta

Am J Prev Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection and Proinflammatory Effects of BTEX within the Human Atherosclerotic Plaque.
Raffaele Marfella, Francesca Carreras, Francesco Prattichizzo, Rosalba La Grotta, Valeria Pellegrini, Celestino Sardu

Environ Sci Technol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardioprotective mechanism of ω-3 fatty acid icosapent ethyl (IPE) in cardiomyocytes: role in high glucose and shear stress-induced mechano-transduction dysregulation.
Ada Pesapane, Lucia Scisciola, Manuela Giovanna Basilicata, Rosaria Anna Fontanella, Nunzia Balzano, Celestino Sardu

Cardiovasc Diabetol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of achieving glycated hemoglobin targets on cardiovascular events/mortality: analysis of the nephropathy in diabetes type 2 trial.
Alfredo Caturano, Vittorio Simeon, Raffaele Galiero, Vincenzo Russo, Luca De Nicola, Celestino Sardu

World J Diabetes· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging Paradigm.
Alfredo Caturano, Davide Nilo, Giovanni Di Lorenzo, Maria Rocco, Giuseppina Tagliaferri, Celestino Sardu

Rev Cardiovasc Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study.
Celestino Sardu, Ludovica Vittoria Marfella, Luca Rinaldi, Ferdinando Carlo Sasso, Domenico Cozzolino

Diabetes Res Clin Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study.
Celestino Sardu, Ludovica Vittoria Marfella, Carlo Fumagalli, Luca Rinaldi, Ferdinando Carlo Sasso

Int J Mol Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-plaque vascularization assessed in contrast-enhanced ultrasound predicts cardiovascular events in type 2 diabetes with no significant carotid atherosclerotic stenosis: a prospective study with therapeutic implications for SGLT2 inhibitor use.
Raffaele Marfella, Ludovica Vittoria Marfella, Carlo Fumagalli, Luca Rinaldi, Ferdinando Carlo Sasso, Celestino Sardu

Eur Heart J Imaging Methods Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study.
Carlo Fumagalli, Mattia Zampieri, Roberto Presta, Greta Pini, Giulia Vetere, Celestino Sardu

Circ Heart Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Combined Therapy with SGLT2i and GLP-1RAs on Atrial Fibrillation Recurrence After Catheter Ablation in Diabetic Cohorts: One-Year Outcomes from Continuous Monitoring.
Celestino Sardu, Raffaele Marfella

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study.
Erica Vetrano, Raffaele Galiero, Vittorio Simeon, Giuseppe Palmiero, Arturo Cesaro, Celestino Sardu

Pharmaceuticals (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study.
Alfredo Caturano, Anna di Martino, Gaetana Albanese, Carmine Coppola, Vincenzo Russo, Celestino Sardu

Acta Diabetol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillator.
Celestino Sardu, Maria Consiglia Trotta, Ludovica Vittoria Marfella, Giovambattista D'Amico, Carmine La Marca

Pharmacol Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients?
Celestino Sardu, Nunzia D'Onofrio, Maria Consiglia Trotta, Maria Luisa Balestrieri, Giovanni Francesco Nicoletti

Diabetes Metab Res Rev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cross-Talk Between the Heart and the Liver: The Involvement of the Mitral Valve as a Novel Actor upon the Ancient Scene of Liver Cirrhosis.
Domenico Cozzolino, Riccardo Nevola, Alberto Ruggiero, Ciro Romano, Giuseppina Rosaria Umano, Celestino Sardu

J Cardiovasc Dev Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications.
Alfredo Caturano, Maria Rocco, Giuseppina Tagliaferri, Alessia Piacevole, Davide Nilo, Celestino Sardu

Antioxidants (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on Antithrombotic Effect of Protopanaxatriol Saponins from Panax notoginseng Using Zebrafish Model.
Alfredo Caturano, Vincenzo Russo, Marcellino Monda, Celestino Sardu, Raffaele Marfella

J Cardiovasc Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease.
Alfredo Caturano, Raffaele Galiero, Maria Rocco, Giuseppina Tagliaferri, Alessia Piacevole, Celestino Sardu

Biomolecules· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care.
Alfredo Caturano, Raffaele Galiero, Maria Rocco, Giuseppina Tagliaferri, Alessia Piacevole, Celestino Sardu

Biomedicines· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions.
Alfredo Caturano, Erica Vetrano, Raffaele Galiero, Celestino Sardu, Luca Rinaldi

Int J Mol Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial.
Roberto Minutolo, Vittorio Simeon, Luca De Nicola, Paolo Chiodini, Raffaele Galiero, Celestino Sardu

Cardiovasc Diabetol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Nanomedicine for Precision Insulin Delivery.
Alfredo Caturano, Roberto Nilo, Davide Nilo, Vincenzo Russo, Erica Santonastaso, Celestino Sardu

Pharmaceuticals (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-Heart Axis: Bridging Physiology to Insulin Resistance.
Alfredo Caturano, Raffaele Galiero, Erica Vetrano, Celestino Sardu, Luca Rinaldi

Int J Mol Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes.
Celestino Sardu, Ludovica Vittoria Marfella, Valerio Giordano, Caterina Claudia Lepre, Giovanbattista D'Amico

Front Pharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis